Electromedical Technologies Stock News

Electromedical Technologies Announces 2021 Annual Financial Results   SCOTTSDALE, AZ -- April 7, 2021 -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain by using frequencies and electro-modulation, is pleased to announce its results for the year ended December 31, 2021. "...

Electromedical Announces Addition of David Orn as Director of Business and Sales Development Orn to Focus on Expansion of Sales and Distribution for Wellness Pro Plus Device   SCOTTSDALE, AZ -- March 8, 2022 -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTC: EMED) ("Electromedical" or the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, is excited to announce that the Company has hired its first Business and...

Electromedical Issues Shareholder Letter from the CEO on the Road Ahead for 2022   SCOTTSDALE, AZ -- January 13, 2022 -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTC: EMED) ("Electromedical" or the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, is pleased to issue the following Annual Letter to Shareholders from the Company's Chief Executive Officer:   Dear Valued Shareholder, Let me...

Electromedical Technologies, Inc. (OTCMKTS:EMED) was the target of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 100 shares, a decline of 99.4% from the October 31st total of 15,400 shares. Based on an average daily trading volume, of 1,817,200 shares, the days-to-cover ratio []

Q3 2021 revenue increased $95,307, a roughly 46% increase over Q3 2020. $1.6M of variable convertible debt converted and settled in the nine months ended September 30, 2021. SCOTTSDALE, Ariz., Nov. 18, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a

Electromedical Technologies, Inc. Reports Third Quarter 2021 Financial Results   Q3 2021 revenue increased $95,307, a roughly 46% increase over Q3 2020. $1.6M of variable convertible debt converted and settled in the nine months ended September 30, 2021.   SCOTTSDALE, AZ -- November 18, 2021 -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and production of bioelectronic devices...

SCOTTSDALE, Ariz., Sept. 30, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and production of bioelectronic devices designed to reli

SCOTTSDALE, Ariz., Aug. 19, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and production of bioelectronic devices designed to relie

SCOTTSDALE, Ariz., Aug. 18, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and production of bioelectronic devices designed to relie

•The Stage I research program now includes development of targeted Alzheimer's Disease therapy using bioelectronics •Experienced neuroscientist Dr. Sholpan Askarova to lead neuromodulation researc

- EMED Director Kathy Strand R.N. hosting booth at Parker Seminars Expo in Orlando June 11th-13th - Parker Seminars hosts semi-annual expo and seminars for chiropractors and their assistants - Presenc

- Studies could lead to development of next-generation targeted devices to effectively treat chronic pain - Stage I research programs designed to study how electro-modulation communicates to cells -

SCOTTSDALE, Ariz., May 25, 2021 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the

- Event with Dr. Jeff Harper to highlight the benefits of the WellnessProPlus® for chronic pain sufferers - Facebook Live Event schedule for TODAY, May 19, 2021 at 2:20 PM CST (12:20pm PST/3:20pm EST